Skip to main content
logo
Biogen Inc. (LON:0R1B)
London flag London · Delayed Price · Currency is GBP · Price in USD
133.27
-1.28 (-0.95%)
At close: Jul 11, 2025

Biogen Revenue

Biogen had revenue of $2.43B USD in the quarter ending March 31, 2025, with 6.13% growth. This brings the company's revenue in the last twelve months to $9.82B, up 1.59% year-over-year. In the year 2024, Biogen had annual revenue of $9.68B, down -1.62%.

Revenue (ttm)
$9.82B
Revenue Growth
+1.59%
P/S Ratio
1.84
Revenue / Employee
$1.29M
Employees
7,605
Market Cap
13.95B GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20249.68B-159.70M-1.62%
Dec 31, 20239.84B-337.80M-3.32%
Dec 31, 202210.17B-808.30M-7.36%
Dec 31, 202110.98B-2.46B-18.32%
Dec 31, 202013.44B-933.30M-6.49%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
AstraZeneca42.56B
GSK plc31.53B
Haleon11.23B
Smith & Nephew4.64B
ConvaTec Group1.83B
Hikma Pharmaceuticals2.50B
HUTCHMED (China)503.39M
Genus671.60M
Revenue Rankings

Biogen News

More News